AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis Biotech Investing
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV Biotech Investing
Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS in Latest ICER Draft Evidence Report Biotech Investing
Lexaria to Present and Meet with Investors One-on-One at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 Biotech Investing
/R E P E A T -- Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067/ Biotech Investing
